Reuters: Regulatory News: FDA approves Bristol Myers, Pfizer's anti-clotting drug Eliquis

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

FDA approves Bristol Myers, Pfizer's anti-clotting drug Eliquis Dec 28th 2012, 21:49 Fri Dec 28, 2012 4:49pm EST Dec 28 (Reuters) - U.S. health regulators approved clot prevention drug Eliquis, developed by Bristol Myers-Squibb Co and Pfizer Inc, for treatment in patients with atrial fibrillation, or irregular heartbeats, not caused by a heart valve problem. The drug, also known as apixaban, was approved by European health regulators last month. It should not be taken by patients with prosthetic heart valves or those with atrial fibrillation caused by a heart valve problem, the U.S. Food and Drug Administration said in a statement. []

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions